Pre-market Hot Trades in US Stocks
Oracle pre-market down 10.94%. Based on recent key news:
<ol>
<li>
On December 10, Oracle failed to meet Wall Street's expectations for its second-quarter revenue and operating profit, leading to a 5.5% drop in stock price during after-hours trading. The company's reported adjusted profit for the quarter was $2.26 per share, higher than analysts' expected $1.64, but revenue fell short of expectations. Source: Reuters
</li>
<li>
On December 10, the market expressed concerns about Oracle's collaboration with OpenAI, as OpenAI faces significant capital expenditures and single-client risks. Analysts pointed out that Oracle's capital expenditures related to OpenAI could impact the company's financial stability. Source: Wall Street Insight
</li>
<li>
On December 11, Oracle announced the sale of its Ampere shares and adopted a chip-neutral policy, with adjusted profits affected by one-time pre-tax gains. This move aims to address market concerns about the sustainability of AI investments. Source: Reuters The AI sector faces scrutiny, and debt risks are rising.
</li>
</ol>
Advanced Biomed, pre-market down 9.87%, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Top Gainers in Pre-market US Stocks
Agape ATP, pre-market up 197.06%, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Galaxy Payroll, pre-market up 38.17%, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Bochi Pets, pre-market up 20.50%. Based on recent news,
<ol>
<li>
On December 11, analysts rated Boch Pets as a sell, with a target price of $2.00. Analysts pointed out that Boch Pets' financial performance is weak, with declining revenue, negative profitability, and severe cash flow issues, while technical analysis also shows a bearish trend. These factors collectively led to Boch Pets' low rating.
</li>
<li>
On December 11, Benzinga's Edge stock ranking indicated that Boch Pets' stock price trends are negative across all time frames. Benzinga advises investors to pay attention to the performance of other companies in this niche market. The overall performance of the pet industry is weak, and investors should be cautious
</li>
</ol>

ORCL

ADVB

Oracle pre-market down 10.94%; Advanced Biomed pre-market down 9.87%; Agape ATP pre-market up 197.06%; Galaxy Payroll pre-market up 38.17%; Boqi Pet pre-market up 20.50%

Pre-market hot trades in US stocks: Oracle down 10.94% pre-market; Advanced Biomed down 9.87% pre-market